/FMEDX
FMEDX Stock - Fidelity Disruptive Medicine Fund
Financial Services|Asset ManagementNASDAQ
$11.28-0.18%
$0.02 (-0.18%) • Jan 24
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.48
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.89
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $12.41
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for FMEDX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$11.17 – $11.39
TARGET (TP)$12.97
STOP LOSS$10.38
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.78
52W High$11.60
52W Low$10.96
Avg VolumeN/A
Income Statement (Fiscal Year)
Loading financial data...
Company Overview
Normally the fund invests at least 80% of assets in securities of disruptive medicine companies. Normally it invests primarily in equity securities. Companies within the disruptive medicine theme include but are not limited to those companies that, in the Adviser's opinion, are engaged in robotic surgery, gene therapy, genomics, rare diseases, medical devices and equipment, immunotherapy, technology-based health care platforms, and consumer wellness. The fund is non-diversified.
Loading analyst ratings...
Earnings History & Surprises
FMEDXLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about FMEDX
What is FMEDX's current stock price?
Fidelity Disruptive Medicine Fund (FMEDX) is currently trading at $11.28 per share. The stock has moved -0.18% today.
What is the analyst price target for FMEDX?
No analyst price targets are currently available for this stock.
What sector is Fidelity Disruptive Medicine Fund in?
Fidelity Disruptive Medicine Fund operates in the Financial Services sector, specifically within the Asset Management industry. The company is traded on the NASDAQ exchange.
What is FMEDX's market cap?
Fidelity Disruptive Medicine Fund has a market capitalization of $0.04 billion, making it a small-cap company.
Does FMEDX pay dividends?
No, Fidelity Disruptive Medicine Fund does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorBSCVX
Bernzott U.S. Small Cap Value Fund
$11.36
Mkt Cap: $0.0B
DBECX
BNY Mellon Diversified Emerging Markets Fund
$21.64
Mkt Cap: $0.0B
FIRWX
Fidelity Simplicity RMD 2020 Fund
$61.60
Mkt Cap: $0.0B
FNETX
Fidelity Disruptive Communications Fund
$12.47
Mkt Cap: $0.0B
FNTEX
Fidelity Disruptive Finance Fund
$13.10
Mkt Cap: $0.0B
IRL
The New Ireland Fund, Inc.
$10.41
Mkt Cap: $0.0B
NBO
Neuberger Berman New York Municipal Fund, Inc.
$8.48
Mkt Cap: $0.0B
OMOAX
Vivaldi Multi-Strategy Fund
$23.63
Mkt Cap: $0.0B
VLHYX
Value Line Tax-Exempt Fund
$9.64
Mkt Cap: $0.0B
Explore stocks similar to FMEDX for comparison